Cullinan Therapeutics, Inc. ($CGEM)
Fenton Mary Kay โ Chief Financial Officer
Shares
4,398
Price
$13.62
Total Value
$59,900.76
Nearby Earnings
Feb 26, 2026
EPS:Est: -0.80
Revenue:Est: $5.56M
Transaction Details
| Insider | Fenton Mary Kay |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Feb 20, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 23, 2026 |
| Shares Sold | 4,398 |
| Price per Share | $13.62 |
| Total Value | $59,900.76 |
| Shares Owned After | 126,380 |
| Derivative | No |
| Accession Number | 0001193125-26-064261 |
| Document | View SEC Filing |